We share the same aspirations as many of our global partners, and as a result, we will continue to bring new, innovative treatments that make tomorrow shine.
Avernus is a regional specialty company established to fill the gap and partner with global pharma and biotech companies to commercialize FDA / EMA-approved innovative pharmaceutics, biologics, and other healthcare solutions across the Middle East. As such, Avernus serves as a one-stop solution for our partners — providing multi-country access across a wide region with growing economies.
We accomplish this by utilizing our Business Development expertise to research innovative new drugs from various parts of the world, and by identifying solutions that facilitate patient access to healthcare and improved outcomes.
To be the leading regional provider of global brands in the pharmaceutical sector, with an innovative marketing approach.
To continually improve the health and quality of people’s lives by providing innovative medications that fulfill unmet medical needs.
We uphold the highest ethical standards in every endeavor — trust is earned, then carefully maintained.
We continually seek creative solutions that improve patient outcomes and shape a healthier tomorrow.
We believe in the power of teamwork — internally and with our partners — to achieve more together.
We pursue quality and impact in everything we do, always asking whether there is a better way — and following it.
We celebrate inclusivity and empower talent from all backgrounds, with equal opportunity at our core.
The dynamics of our industry require us to stay relentlessly alert and to take full advantage of the opportunities generated by evolving biopharmaceutical science. We systematically monitor scientific progress by seeking new products, partnerships, and markets — guided by a strong commitment to quality and excellence.
We invest in long-term relationships with our international partners, aiming to be their partner of choice for new products and lines across the Gulf & Middle East.
We keep high-quality standards across all our activities to effectively address the needs of patients, the medical community, employees, and customers.
Responsibility sits at the core of our culture, strategy, and daily operations — defined by professionalism, transparency, and accountability.
Our Compliance Management System details how the company fulfills its obligations under the legislative framework, applicable Codes of Practice, vendor contracts, and SOPs — expressing our commitment to ethical business practices that every staff member upholds.
Avernus is the marketing arm of the ZAS Group, leveraging in-depth market knowledge and a strong retail and distribution arm. ZAS is a family-owned company with a hands-on approach to management, consisting of 13 business units that partner with global international brands — each bringing specialized industry expertise to the table.
ZAS Group started in 1976, spearheaded by Al Ain Pharmacy (APG) as a leader in pharmacy retail in the UAE. The group operates a shared infrastructure — warehousing, distribution, logistics, HR, administration, finance, and IT — creating synergies that underpin an ambitious program for growth.
ZAS
Our global collaborations
In India
Pharma companies choose to cooperate with Avernus, acknowledging our team’s long-term expertise in pharmaceutical sales, marketing, and distribution — expertise that drives powerful growth and a commitment to excellence, quality, and responsibility.
Working closely with senior leadership, our Business Development function keeps Avernus ahead of evolving market dynamics — exploring and assessing future collaborations, adding value in portfolio & pipeline management, and providing critical market research, full business plans, and innovative launch support so your products reach their full potential.
Avernus continues to create and deliver value to patients as efficiently as possible, with the right partners. Take the next step toward innovation, growth, and positive change across the region.